glp1受体激动剂杜拉鲁肽治疗2型糖尿病的疗效观察研究:西班牙的现实研究

{"title":"glp1受体激动剂杜拉鲁肽治疗2型糖尿病的疗效观察研究:西班牙的现实研究","authors":"A. Oleaga","doi":"10.19080/crdoj.2022.15.555918","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":411114,"journal":{"name":"Current Research in Diabetes & Obesity Journal","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Observational Study on the Effectiveness of Treatment with the GLP1-Receptor Agonist Dulaglutide in Patients with Type 2 Diabetes Mellitus: Real-Life Study in Spain\",\"authors\":\"A. Oleaga\",\"doi\":\"10.19080/crdoj.2022.15.555918\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":411114,\"journal\":{\"name\":\"Current Research in Diabetes & Obesity Journal\",\"volume\":\"37 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Research in Diabetes & Obesity Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/crdoj.2022.15.555918\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Diabetes & Obesity Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/crdoj.2022.15.555918","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}